| Symbol |
Name |
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADD3
|
adducin 3 (gamma)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
APOL3
|
apolipoprotein L, 3
|
|
ART4
|
ADP-ribosyltransferase 4 (Dombrock blood group)
|
|
ATF3
|
activating transcription factor 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
C1R
|
complement component 1, r subcomponent
|
|
C1S
|
complement component 1, s subcomponent
|
|
CBX7
|
chromobox homolog 7
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL5A2
|
collagen, type V, alpha 2
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
CRMP1
|
collapsin response mediator protein 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
EDNRA
|
endothelin receptor type A
|
|
EFHD1
|
EF-hand domain family, member D1
|
|
EFNB2
|
ephrin-B2
|
|
EGR1
|
early growth response 1
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
EZR
|
ezrin
|
|
FDXR
|
ferredoxin reductase
|
|
FN1
|
fibronectin 1
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GATA2
|
GATA binding protein 2
|
|
GPM6B
|
glycoprotein M6B
|
|
HEPH
|
hephaestin
|
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2
|
|
HOXA5
|
homeobox A5
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
JUN
|
jun proto-oncogene
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
LEPR
|
leptin receptor
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MEST
|
mesoderm specific transcript
|
|
MFAP2
|
microfibrillar-associated protein 2
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A
|
|
MSX1
|
msh homeobox 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAMPTP1
|
nicotinamide phosphoribosyltransferase pseudogene 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFIB
|
nuclear factor I/B
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
ODC1
|
ornithine decarboxylase 1
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDLIM1
|
PDZ and LIM domain 1
|
|
PLP1
|
proteolipid protein 1
|
|
PRKCB
|
protein kinase C, beta
|
|
PTCH1
|
patched 1
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
RTN3
|
reticulon 3
|
|
SATB2
|
SATB homeobox 2
|
|
SMAD7
|
SMAD family member 7
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SULF1
|
sulfatase 1
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TNXA
|
tenascin XA (pseudogene)
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TYMS
|
thymidylate synthetase
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|